Cargando…

Update on Recent Advances in the Management of Aspirin Exacerbated Respiratory Disease

Aspirin intolerant asthma (AIA) is frequently characterized as an aspirin (ASA)-exacerbated respiratory disease (AERD). It is a clinical syndrome associated with chronic severe inflammation in the upper and lower airways resulting in chronic rhinitis, sinusitis, recurrent polyposis, and asthma. AERD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palikhe, Nami Shrestha, Kim, Joo-Hee, Park, Hae-Sim
Formato:	Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2009
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2796398/ https://www.ncbi.nlm.nih.gov/pubmed/20046412 http://dx.doi.org/10.3349/ymj.2009.50.6.744

Ejemplares similares

Genetic Mechanisms in Aspirin-Exacerbated Respiratory Disease
por: Shrestha Palikhe, Nami, et al.
Publicado: (2012)

Role of Toll-like Receptor 3 Variants in Aspirin-Exacerbated Respiratory Disease
por: Palikhe, Nami Shrestha, et al.
Publicado: (2011)

Polymorphisms of Aspirin-Metabolizing Enzymes CYP2C9, NAT2 and UGT1A6 in Aspirin-Intolerant Urticaria
por: Palikhe, Nami Shrestha, et al.
Publicado: (2011)

Aspirin Exacerbated Respiratory Disease
por: Teran, Luis M., et al.
Publicado: (2012)

Update on the Management of Aspirin-Exacerbated Respiratory Disease
por: Buchheit, Kathleen M., et al.
Publicado: (2016)

IL-13 Gene Polymorphisms are Associated With Rhinosinusitis and Eosinophilic Inflammation in Aspirin Intolerant Asthma
por: Palikhe, Nami Shrestha, et al.
Publicado: (2010)

Biomarkers Predicting Isocyanate-Induced Asthma
por: Palikhe, Nami Shrestha, et al.
Publicado: (2011)

No evidence of association between interleukin-13 gene polymorphism in aspirin intolerant chronic urticaria
por: Palikhe, Nami Shrestha, et al.
Publicado: (2009)

Aspirin-exacerbated respiratory disease: Update on medical management
por: White, Andrew A., et al.
Publicado: (2020)

Which Factors Associated With Activated Eosinophils Contribute to the Pathogenesis of Aspirin-Exacerbated Respiratory Disease?
por: Choi, Youngwoo, et al.
Publicado: (2018)

Aspirin-Exacerbated Respiratory Disease: Evaluation and Management
por: Lee, Rachel U., et al.
Publicado: (2011)

Exploration of the Sphingolipid Metabolite, Sphingosine-1-phosphate and Sphingosine, as Novel Biomarkers for Aspirin-exacerbated Respiratory Disease
por: Trinh, Hoang Kim Tu, et al.
Publicado: (2016)

Exonic Variants Associated with Development of Aspirin Exacerbated Respiratory Diseases
por: Shin, Seung-Woo, et al.
Publicado: (2014)

A genetic effect of IL-5 receptor α polymorphism in patients with aspirin-exacerbated respiratory disease
por: Losol, Purevsuren, et al.
Publicado: (2013)

Effect of TGF-β1 on eosinophils to induce cysteinyl leukotriene E(4) production in aspirin-exacerbated respiratory disease
por: Choi, Youngwoo, et al.
Publicado: (2021)

Aspirin Exacerbated Respiratory Disease: Epidemiology, Pathophysiology, and Management
por: Li, Kevin L., et al.
Publicado: (2019)

Association of eosinophil‐derived neurotoxin levels with asthma control status in patients with aspirin‐exacerbated respiratory disease
por: Ban, Ga‐Young, et al.
Publicado: (2023)

Nasal Transcriptome and Epigenome Analysis Identifies the Pathogenic Features of Aspirin-Exacerbated Respiratory Disease
por: Kwon, Eun-Kyung, et al.
Publicado: (2023)

Aspirin-exacerbated respiratory disease: pathophysiological insights and clinical advances
por: Steinke, John W, et al.
Publicado: (2016)

Rhinosinusitis and Aspirin-Exacerbated Respiratory Disease
por: Garcia Cruz, Maria L., et al.
Publicado: (2012)

Integrative information theoretic network analysis for genome-wide association study of aspirin exacerbated respiratory disease in Korean population
por: Wang, Sehee, et al.
Publicado: (2017)

Nasal lysine aspirin challenge in the diagnosis of aspirin - exacerbated respiratory disease
por: Miller, B, et al.
Publicado: (2013)

The role of aspirin desensitization in patients with aspirin-exacerbated respiratory disease (AERD)()
por: Spies, Jonas Willian, et al.
Publicado: (2015)

Biomarkers for predicting response to aspirin therapy in aspirin‐exacerbated respiratory disease
por: Tyrak, Katarzyna E., et al.
Publicado: (2021)

Aspirin‐exacerbated respiratory disease: A review
por: Dominas, Christine, et al.
Publicado: (2020)

Increased expression of serine palmitoyl transferase and ORMDL3 polymorphism are associated with eosinophilic inflammation and airflow limitation in aspirin-exacerbated respiratory disease
por: Ban, Ga-Young, et al.
Publicado: (2020)

Aspirin induces IL-4 production: augmented IL-4 production in aspirin-exacerbated respiratory disease
por: Kong, Su-Kang, et al.
Publicado: (2016)

Emerging Biomarkers Beyond Leukotrienes for the Management of Nonsteroidal Anti-inflammatory Drug (NSAID)-Exacerbated Respiratory Disease
por: Rhyou, Hyo-In, et al.
Publicado: (2022)

Audit of nasal lysine aspirin therapy in recalcitrant aspirin exacerbated respiratory disease
por: Howe, Rachel, et al.
Publicado: (2014)

Recent update on the management of anaphylaxis
por: Quoc, Quang Luu, et al.
Publicado: (2021)

Long-term efficacy of anti-IL-4 receptor antibody in a patient with aspirin-exacerbated respiratory disease and IgG4-related disease
por: Jeon, Hyun-Seob, et al.
Publicado: (2023)

Olfactory outcomes in the management of aspirin exacerbated respiratory disease related chronic rhinosinusitis
por: Spielman, Daniel B., et al.
Publicado: (2020)

The utility of biomarkers in diagnosis of aspirin exacerbated respiratory disease
por: Comhair, Suzy A. A., et al.
Publicado: (2018)

Appropriate extent of surgery for aspirin-exacerbated respiratory disease
por: Muhonen, Ethan G., et al.
Publicado: (2020)

Aspirin Actions in Treatment of NSAID-Exacerbated Respiratory Disease
por: Sehanobish, Esha, et al.
Publicado: (2021)

Aspirin Exacerbated Respiratory Disease and Nasal Polyp Phenotyping
por: Kaboodkhani, Reza, et al.
Publicado: (2021)

Diagnostic Value of Clinical Parameters in the Prediction of Aspirin-Exacerbated Respiratory Disease in Asthma
por: Chang, Hun Soo, et al.
Publicado: (2011)

3017- Basic and clinical immunology – 3017: A functional polymorphism in IL-5 receptor alpha may influence asthma severity in patients with aspirin-exacerbated respiratory disease
por: Losol, Purevsuren, et al.
Publicado: (2013)

Potential Biomarkers for NSAID-Exacerbated Respiratory Disease
por: Park, Hanki, et al.
Publicado: (2017)

Pathogenesis of NSAID-induced reactions in aspirin-exacerbated respiratory disease
por: Laidlaw, Tanya M.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6mtru01c9is2ls1927a5admqa5